SCHEDULE: Wasatch Advisors LP Reports 0.5% Stake in Inspire Medical
Beneficial Ownership Report
Wasatch Advisors LP has filed an amended Schedule 13G, disclosing a 0.5% beneficial ownership stake in Inspire Medical Systems Inc, holding 135,914 shares.
Summary
- Wasatch Advisors LP, an investment adviser, reported beneficial ownership of 135,914 shares of Inspire Medical Systems Inc. common stock.
- This ownership represents 0.5% of the class of securities.
- Wasatch Advisors LP holds sole voting power and sole dispositive power over all 135,914 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine disclosure of institutional ownership below the 5% threshold, indicating continued but not significantly increased or decreased interest.
Positives
- Continued institutional investment by Wasatch Advisors LP in Inspire Medical Systems Inc.
Negatives
- The reported 0.5% stake is relatively small and does not indicate a significant new position or strong conviction that would materially impact the company's valuation or strategic direction.
Industry Context
Inspire Medical Systems Inc. operates in the medical device industry, focusing on solutions for sleep apnea. This filing indicates ongoing, albeit minor, institutional interest from an investment adviser, which is a common occurrence for publicly traded companies in the healthcare sector.
Stakeholder Impact
- Shareholders may note the continued, albeit small, institutional investment in the company.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event which requires filing of this statement |
| 11/12/2025 | Signature date of the filing by Wasatch Advisors LP |
Recommendation
holdThis Schedule 13G filing is a routine disclosure of institutional ownership by Wasatch Advisors LP, reporting a 0.5% stake in Inspire Medical Systems Inc. The reported ownership is below the 5% threshold, and the filing does not contain any new material information regarding the company's operations, financial performance, or strategic direction. Therefore, it does not warrant a change in investment thesis, suggesting a 'hold' recommendation for existing investors.
Keywords
Inspire Medical Systems, Wasatch Advisors, Schedule 13G, institutional ownership, medical devices, sleep apnea, investment adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.